India · English
Natco Pharma raises proposed investment in eGenesis to $16.70 million
The drug maker said the investment will support new-age therapeutic programmes focused on critical unmet medical needs.
Read the full report at The Hindu BusinessLine →
How 2 newsrooms ran it
2 of our sources carried this story over 2.5 hours. The Hindu BusinessLine filed first, at 05:35 IST. The headlines below are each outlet's own wording, in the order they published.
| Time IST | Outlet | Their headline |
|---|---|---|
| 05:35 | The Hindu BusinessLine | Natco Pharma raises proposed investment in eGenesis to $16.70 million |
| 08:07 | Business Standard | Natco Pharma hikes investment in US-based eGenesis to $16.7 million |
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.